CanBas Co. Ltd.

CanBas Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY86.49
Market Cap
JPY5.99 B
Shares Outstanding
6.83 M
Public Float
5.54 M

Profile

Address
2-2-1 Otemachi
Numazu Shizuoka 410
Japan
Employees -
Website http://www.canbas.co.jp
Updated 07/08/2019
CanBas Co., Ltd. engages in pharmaceutical business. It focuses on the research and development of anti-cancer agent, drugs, and technologies which has minor impact on normal cell. Its technologies include drugs for the G2 check point and a screening system to find selective abrogates of the G2 check point.

Financials

View All

Takumi Kawabe
President & Representative Director
Makoto Katozumi
CFO, Director & Manager-Administration